Open AccessResponse-guided treatment of cirrhotic chronic hepatitis B patients: Multicenter prospective study
Author(s) -
Erli Gu,
Yiqi Yu,
Jiali Wang,
Yanyan Ji,
Ma Xiuyun,
Qing Xie,
Hongying Pan,
Shan-Min Wu,
Jun Li,
Cheng-Wei Chen,
Xiaowei Xu,
Yue-Er Wang,
Guangbi Yao,
Hong Wang,
Wenhong Zhang
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i2.653
Subject(s) - medicine , adefovir , lamivudine , gastroenterology , cirrhosis , hepatitis b virus , hepatitis b , liver function , entecavir , combination therapy , immunology , virus
To observe the effect of response-guided add-on therapy with adefovir (ADV) and lamivudine (LAM) in cirrhotic hepatitis B (CHB) patients.